Background and Purpose-It is hypothesized that tissue plasminogen activator rescues brain tissue by improving perfusion. In this study, we aimed to examine acute regional perfusion changes and how they influence infarction and clinical outcome. Methods-Three sequential MR scans were performed in 15 tissue plasminogen activator-treated patients within 3.5 (tp1), at 6 hours (tp2), and at 1 month (tp3) after stroke onset. "Hypoperfusion" was defined if mean transit time prolongation was more than a threshold (4 thresholds: 3, 4, 5, and 6 seconds). Four regions of interest were classified: (1) "reperfusion"-hypoperfused at tp1, normal at tp2; (2) "nonreperfusion"-hypoperfused at tp1 and tp2; (3) "normal perfusion"-normal at tp1 and tp2; and (4) "new hypoperfusion"-normal at tp1 and hypoperfused at tp2. Risk of infarction was calculated within each region of interest. Associations between tissue perfusion changes and clinical variables were evaluated using stepwise multiple linear regressions. Moreover, the association between National Institutes of Health Stroke Scale changes and perfusion alterations was assessed using linear mixed effect models. Results-Regardless of the mean transit time threshold chosen, the risk of infarction in nonreperfused regions (40% to 68%, thresholds 3 to 6 seconds) was higher than reperfused regions (9% to 30%, PϽ0.05), and it was higher in new hypoperfusion regions (9% to 33%) than normal perfusion regions (3% to 4%, PϽ0.05). Volume of new hypoperfusion was significantly associated with onset-to-treatment time and initial hypoperfused volume. Overall relative reperfusion was significantly associated with National Institutes of Health Stroke Scale improvement. Key Words: cerebral perfusion Ⅲ hypoperfusion Ⅲ ischemic stroke Ⅲ reperfusion Ⅲ tPA R estoration of blood flow to ischemic regions in a timely manner enhances clinical improvement. 1,2 Moreover, tissue reperfusion is thought to be the leading mechanism underlying the efficacy of intravenous recombinant tissue plasminogen activator (tPA). [3] [4] [5] [6] [7] [8] [9] If reperfusion occurs early, it may promote survival in vulnerable tissue that would otherwise progress to infarction without reperfusion. 9,10 Despite the importance of time-to-reperfusion on clinical outcome after stroke, few studies have critically examined tissue perfusion changes within the first several hours after stroke onset.
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Although recanalization or reperfusion in acute stroke may occur either by medical intervention or spontaneously up to several days after stroke onset, clinical benefit from reperfusion-promoting therapies has only been found if it is given within 6 hours from symptom onset. 2, 9, 11 Thus, to understand clinically relevant reperfusion, studies should be conducted within this 6-hour window. The Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) 9 and Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) 10 studies examined diffusionperfusion mismatch at 2 time points during acute ischemic stroke. The 2 studies differed with respect to the time for assessing reperfusion with a median of 9 hours for DEFUSE and a median of 3 days for EPITHET. Given the delayed assessment of reperfusion beyond the clinically relevant reperfusion time window, these studies may have underestimated the impact of early reperfusion. In this study, we hypothesize that there are substantial temporal and spatial heterogeneities in tissue reperfusion within 6 hours from stroke onset and the extent to which tissue reperfusion may depend on baseline clinical variables and initial lesion volumes. Voxel-based analysis, using a 6-hour assessment for reperfusion in a cohort of hyperacute tPA-treated patients with ischemic stroke, we measured the effects of perfusion alterations on risk of infarction at 1 month. Moreover, associations between perfusion alterations and clinical variables such as onset-to-treatment time (OTT) and change in the National Institutes of Health Stroke Scale (NIHSS) were evaluated.
Methods

Patients and Inclusion Criteria
All protocols were approved by the Institutional Review Board. Consecutive patients within 3 hours of stroke onset were considered for enrollment based on the following prespecified inclusion criteria: clinically suspected cortical acute ischemic stroke; age Ն18 years; NIHSS Ն5; could be imaged immediately after tPA bolus (within approximately 3.5 hours of stroke onset); and patient or patient's next of kin capable of informed consent. Exclusion criteria included bilateral strokes or any acute endovascular or surgical intervention. In this study, only tPA-treated patients were included for subsequent data analysis. Patients were given intravenous tPA according to the National Institutes of Neurological Disorders and Stroke tPA trial protocol. 4 The study imposed no delay in time-to-tPA treatment and no deviation from standard monitoring practices. The NIHSS was obtained on admission and at all imaging time points.
MRI Protocol
Patients were scanned with MRI at 3 time points: within 3.5 hours (tp1), at 6 hours (tp2), and at 1 month (tp3) after stroke onset. The tp1 scan was performed as soon as possible, usually at the time tPA was infusing. MR images were acquired on a 3-T Siemens wholebody Trio system (Siemens Medical Systems, Erlangen, Germany) with a circular polarized head coil. The imaging protocol included diffusion-weighted images, T2-weighted fluid-attenuated inversion recovery images (TR/TEϭ10000/115 ms; inversion timeϭ2500 ms; matrixϭ512ϫ416; 20 slices, slice thicknessϭ5 mm), and dynamic susceptibility contrast perfusion imaging (a T2*-weighted gradient echoplanar imaging sequence; TR/TEϭ1500/43 ms; 14 slices, slice thicknessϭ5 mm, zero interslice gap; matrixϭ128ϫ128). The dynamic susceptibility contrast sequence was repeated 50 times with contrast injection on the fifth measure using 0.1 mmol/kg gadolinium diethylenetriamine penta-acetic acid at a rate of 5 mL/s with a power injector followed by a 15-mL bolus of saline. MR angiography was not performed.
Data Analysis
For dynamic susceptibility contrast perfusion imaging, we followed established procedures 12 for the estimation of mean transit time (MTT) by using the ratio between cerebral blood volume and cerebral blood flow as MTTϭcerebral blood volume/cerebral blood flow. Voxels within the middle cerebral artery of the contralateral hemisphere were manually chosen to obtain an arterial input function.
Six parameter rigid image registration was performed to align dynamic susceptibility contrast and fluid-attenuated inversion recovery images across all scans for each patient using a well-established registration package, FSL 3.2 (FMRIB, Oxford, UK). 13 Accuracy of image registration was evaluated manually by checking multiple structural landmarks such as the ventricle and brain boundaries in all registered images and their corresponding template image for each patient.
MTT was chosen to define perfusion status because MTT is uniform across gray and white matter (unlike cerebral blood flow or cerebral blood volume), allowing for use of a single threshold across both gray and white matter. 14 -16 MTT prolongation was computed by subtracting the mean MTT value for the contralateral hemisphere from the MTT value in the ischemic hemisphere for each voxel. A voxel was defined as "hypoperfused" if MTT prolongation was greater than or equal to a predefined threshold or normal otherwise. Because the abnormal lesion volume varies depending on the MTT threshold chosen, [17] [18] [19] [20] 4 MTT prolongation thresholds (3, 4, 5, and 6 seconds) were tested to determine if results were consistent across a range of putative thresholds.
Four different categories of regions were defined based on the initial perfusion status at tp1 and its subsequent change at tp2. For regions with initial abnormal perfusion on tp1, 2 different perfusion patterns were defined: (1) "reperfusion," hypoperfused at tp1, normal at tp2; and (2) "nonreperfusion," hypoperfused at tp1 and tp2. Moreover, for initially normal perfused regions at tp1, 2 different perfusion patterns were defined: (3) "normal perfusion," normal at both tp1 and tp2; and (4) and "new hypoperfusion," normal at tp1 and hypoperfused at tp2 (Table 1) . Isolated regions Ͻ1 mL were removed from the analysis to minimize inclusion of regions of misregistration or noise-induced variations.
The absolute volume of the hypoperfused region at tp1 was defined as V hypo_tp1 . The absolute volumes of reperfusion (V reperf ) and new hypoperfusion (V newhypo ) from each patient were obtained. Subsequently, the absolute net change of reperfused volume (V netchange ) was calculated as V reperf ϪV newhypo with a positive V netchange indicating a net improvement in perfusion at tp2. Relative volumes of reperfusion (%V reperf ), new hypoperfusion (% V newhypo ), and net change (%V netchange ) were computed as V reperf /V hypo_tp1 , V newhypo /V hypo_tp1 , and V netchange /V hypo_tp1 , respectively.
Final lesions were outlined independently by a neuroradiologist (R.P.) and a stroke neurologist (A.F.) as hyperintense regions on the tp3 fluid-attenuated inversion recovery images. An evaluation of the interoperator agreement was performed with a similarity index using the Dice coefficient 21 computed as 2 AപB /( A ϩ B ), where A and B are the final infarct outlined by each operator, respectively. The similarity index ranges from 0 to1 with 0 and 1 corresponding to no and perfect agreement, respectively.
Final lesions were mapped back to the tp1 and tp2 MTT maps. To evaluate the fate of these regions, risks of infarction in the regions of reperfusion, nonreperfusion, new hypoperfusion, and normal perfusion were computed as the ratio of the number of infarcted voxels to the total number of voxels for a specific region.
Statistical Analysis Variance Across MTT Thresholds and Infarction Risk
To evaluate whether varying the MTT threshold would affect the volumes of different perfusion regions, nonparametric repeatedmeasures analysis of variance (Friedman test) was used. Moreover, to assess whether MTT values differed between reperfused and nonreperfused regions at tp1 and between new hypoperfused regions and normal perfused regions at tp1, nonparametric unpaired comparison (Mann-Whitney test) was performed. The risk of infarction within the regions of reperfusion and nonreperfusion were compared as well as between normal perfusion and new hypoperfusion using nonparametric unpaired comparisons (Mann-Whitney test). 
Association Between Change of Tissue Perfusion and Baseline Clinical Variables
Baseline clinical variables, including OTT, age, systolic and diastolic blood pressure, and glucose level, were obtained from all patients. To examine the association between the clinical variables and the absolute or relative volumes of reperfusion, new hypoperfusion, and net perfusion change, a stepwise multiple linear regression analysis was performed (SAS 9.2; SAS Institute Inc, Cary, NC). Stepwise linear regression was used to select the independent variables that might yield a potential association (F statistic, PϽ0.15). In the final linear regression model, a probability value Ͻ0.05 was considered significant.
Association Between Clinical Outcome and Change of Tissue Perfusion
Four linear mixed effect models (SAS 9.2) were used to examine the association between temporal NIHSS change and V reperf , V netchange, %V reperf , and %V netchange , respectively. Overall change in NIHSS (from scores obtained at admission, tp1, tp2, and tp3, constructed as a vector) was modeled as the dependent variable, whereas baseline clinical variables and each of the V reperf , V netchange, %V reperf , and %V netchange were considered as fixed effects in each mixed effect model. Within-subject correlations of repeated NIHSS measurements at various times were accounted for.
Results
Fifteen patients with ischemic stroke treated with intravenous tPA (1.8Ϯ0.5 hours from symptom onset) were imaged with MRI at 2.7Ϯ0.7 hours (tp1) and 6.4Ϯ0.5 hours (tp2) after onset. Thirteen patients had a 1-month follow-up scan (tp3) to determine the final infarct. The tp1 scan was performed at the time tPA was still infusing in 12 patients and begun shortly after the completion of tPA in the remaining 3 patients. The time interval between the end of tPA infusion and the tp2 scan was 3.6Ϯ0.7 hours. Patient demographics including baseline clinical information are shown in Table 2 . All patients had middle cerebral artery strokes with mean NIHSS equal to 14.
Background susceptibility effects manifested as signal void and geometric distortion were occasionally observed in the anterior portion of brain in the dynamic susceptibility contrast images but did not localize within the ischemic lesion. Moreover, unlike the nonlinear transformation, the rigid image registration was insensitive to these local signal changes. The coregistered images were well-aligned with the template images yielding inaccuracies Ͻ3 voxels in any direction.
Perfusion Alterations Between tp1 and tp2
Changes in perfusion status between tp1 and tp2 were studied by examining regions of reperfusion, nonreperfusion, normal perfusion, and new hypoperfusion (Table 1) using 4 MTT thresholds (3, 4, 5, and 6 seconds). Several MTT thresholds were used to evaluate whether the major findings depend on a specific threshold. As anticipated, the initial ischemic volume decreased significantly with each increase in MTT threshold (PϽ0.001). Across different MTT thresholds, several findings were consistently detected ( (4) tp1 MTT values in the new hypoperfused regions were higher than tp1 MTT values in normal perfused regions (PϽ0.05). The constancy of these points regardless of MTT threshold is illustrated in the scatterplots (Figure 1) , which show the absolute and relative volumes of reperfusion, new hypoperfusion, and net change obtained using the 4 MTT thresholds.
MTT maps from 2 representative patients are shown in Figure 2 . For Patient 1 (upper panel), the majority of the initially hypoperfused brain region (Figure 2A ) reperfused at tp2 ( Figure 2C-D, green) , whereas a small region had no reperfusion ( Figure 2B, yellow) . A small region of new hypoperfusion (or delayed hypoperfusion) was observed at tp2 ( Figure 2C-D, red) . In contrast, Patient 2 (lower panel) showed only a small region of reperfusion at tp2 ( Figure  2G -H, green) but had a large new hypoperfused region at tp2 ( Figure 2G-H, red) . For all patients, the areas of new hypoperfusion were found within the affected middle cerebral artery ischemic territory and were not seen within other vascular distributions such as anterior or posterior cerebral artery territories.
Risk of Infarction
The interoperator similarity index for manually defined final lesion areas was 0.87Ϯ0.1, suggesting good agreement between the operators. One set of regions of interest (A.F.) was used for final infarction analysis. On tp2 or tp3 imaging, there were no new areas of restricted diffusion or infarction outside of the initially affected territory. For brain tissue that was hypoperfused at tp1, the risk of infarction in nonreperfused regions was higher than the reperfused regions (PϽ0.05, Mann-Whitney test). For tissue that was normally perfused at 
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tp1, the risk of infarction in the new hypoperfused regions was higher than the normal perfusion regions (PϽ0.05, Mann-Whitney test; Table 3 ).
Association Between Tissue Perfusion Changes and OTT and Initial Hypoperfusion
Although no association was found between the absolute volume of reperfusion (V reperf ) and other baseline variables, including OTT or V hypo_tp1 ( Figure 3A) , a negative association was found between the relative volume of reperfusion (%V reperf ) and the volume of hypoperfusion at tp1 (V hypo_tp1 ; rϭϪ0.67, PϽ0.01, Figure 3B ). The volume of new hypoperfusion (V newhypo ) correlated positively with the tp1 volume of hypoperfusion (V hypo_tp1 ) and OTT (rϭ0.76, PϽ0.05, Figure  3C ). Taken together, these findings suggest that large strokes are less likely to reperfuse and more likely to develop new regions of hypoperfusion. Moreover, a shorter OTT may minimize the development of new hypoperfusion. In agreement with these results, the relative volume of new hypoperfusion (%V newhypo ) correlated positively (rϭ0.57, PϽ0.05, Figure 3D ) and volume of net change in perfusion (V netchange ) correlated negatively with OTT (rϭϪ0.59, PϽ0.01, Figure  3E ). Additionally, both volume of hypoperfusion at tp1 (V hypo_tp1 ) and OTT correlated negatively with relative volume of net change (%V netchange ; rϭϪ0.82, PϽ0.05, Figure  3F ), suggesting that a large region of early ischemia and a prolonged OTT may result in less overall improvement in perfusion status.
Association Between Tissue Perfusion Changes and Clinical Outcomes
Across the study cohort, NIHSS decreased from admission to tp3 (PϽ0.0001). When comparing the 4 different MTT thresholds, an interesting pattern emerged. MTT prolongation thresholds of 3 and 4 seconds showed an association between temporal NIHSS change and %V reperf (PϽ0.05, thresholdϭ3 seconds, Pϭ0.066 thresholdϭ4 seconds). In addition, a similar association was found between temporal NIHSS and %V netchange (PϽ0.05 for both thresholds of 3 and 4 seconds). No significant association was detected when using thresholds of 5 and 6 seconds. These findings may suggest that MTT thresholds Ͻ4 seconds delineate both reversibly and irreversibly injured tissue, whereas MTT thresholds Ͼ5 seconds delineates only irreversibly injured tissue. Thus, applying the more strict thresholds (MTT Ͼ5 seconds), reperfusion does not correlate well with clinical improvement because regions with moderate perfusion deficit were excluded.
Discussion
The current voxel-by-voxel analysis of serial images focuses on tissue perfusion alterations after tPA treatment within 6 hours after stroke onset. We have observed substantial spatial and temporal heterogeneity of tissue perfusion in 15 tPAtreated patients. We demonstrated that tissue outcome depends on the evolution of tissue perfusion in the hyperacute phase of ischemic stroke with nonreperfused regions showing the highest infarction rate. Moreover, we have found that many patients with stroke develop regions of new hypoperfusion, or "delayed hypoperfusion"; these regions increase infarct probability compared with normally perfused tissue. Finally, NIHSS improvement was significantly associated with overall change in perfusion status (%V netchange ).
New Hypoperfusion
Regardless of the MTT threshold chosen, we observed the phenomenon of delayed or new hypoperfusion: normally perfused brain tissue at tp1, which becomes hypoperfused at tp2 (Table 1 ). All regions of new hypoperfusion fell within or were contiguous with the same arterial territory that was initially affected. No distinct regions to suggest emboli or recurrent strokes as the cause of new hypoperfusion were identified. Potential mechanisms that may result in new hypoperfusion include disorders of the macrocirculation such as failure of collaterals, 22 clot progression, 23 and recanalization followed by reocclusion. 24 In addition, disorders of the microvasculature may also be implicated. For example, after severe ischemia, injured edematous capillary endothelial cells may lead to microvascular occlusion accompanied by fibrin, platelet, and leukocyte plugging. Thus, even with recanalization, distal vessels may not reperfuse, termed "no reflow." [25] [26] [27] [28] This procoagulant and inflammatory process may also lead to new areas of hypoperfusion. In addition, microemboli of atherosclerotic debris may be released into the microcirculation causing further distal embolization after thrombolysis. 29 Finally, peri-infarct depolarizations may also contribute to new hypoperfusion. Peri-infarct depolarizations are waves of spreading depression adjacent to ischemic tissue, which result in progressive decreases in blood flow and infarct growth. This novel phenomenon has been studied in animal models 30, 31 and has been reported in human subjects during early stroke. 32
Association Between Perfusion Alterations and Baseline Clinical Variables and Outcomes
We found that delay to tPA treatment was independently associated with new hypoperfusion, suggesting that earlier 4, 5 We found that the initial hypoperfused volume correlated positively with the volume of new hypoperfusion and negatively with relative volume of reperfusion. Furthermore, we found that the nonreperfused regions have significantly higher tp1 MTT values than the reperfused regions. These findings may suggest that larger regions and more severe early ischemia are less likely to reperfuse, resulting in a lower probability of tissue salvage. This is consistent with previous clinical studies that have demonstrated that baseline clinical stroke severity, baseline hypoperfusion severity, and large vessel occlusion are the strongest predictors of stroke evolution and early neurological deterioration. 33, 34 For MTT thresholds Յ4 seconds, NIHSS reduction as a function of time was associated with relative volume of improved perfusion but not with absolute volume. In this study, the clinical improvement over time is a relative measure for a specific patient and it correlated with how much of the initial ischemic volume improved proportionally (relative improvement). We also expect that the location of the initial lesion may play an important role in affecting the NIHSS change. A larger patient population may allow such investigation in the future. Furthermore, we did not find an association between NIHSS change and reperfusion for MTT thresholds of Ն5 seconds. These data may corroborate prior studies, which have found similar perfusion thresholds for distinguishing between functionally impaired, reversibly injured tissue and structurally impaired irreversibly injured tissue. 35, 36 Our study has several limitations. Due to the small sample size in our study, the multiple associations between perfusion alterations and baseline clinical variables tested (Figure 3 ) may not have optimal statistical power. Given the limited number of patients in this study, 3 associations ( Figure 3C , D, F) with a PϽ0.05 should be considered as marginally significant, whereas the other 2 associations ( Figure 3B , E) with a PϽ0.01 showed stronger correlations. Future study with a larger sample size is needed for further investigation. In addition, our study population did not include untreated patients (only patients treated with intravenous tPA). Therefore, we cannot be certain of how tPA may affect the development of delayed hypoperfusion given the lack of a control group. Moreover, we were unable to assess how tissue perfusion alterations affect clinical outcomes in our tPAtreated group relative to patients who do not receive tPA. Our study included moderate to large strokes with mean NIHSS of 14 and thus our results may not apply to patients with smaller strokes. Limited tissue reperfusion may be attributed to the short time interval between tPA administration and tp2. However, the majority of reperfusion after tPA is thought to occur within 2 hours in some studies. 24, 37, 38 Moreover, given the known narrow therapeutic time window, this analysis of early reperfusion is likely to be more clinically meaningful. Finally, image coregistration was performed to align images across all time points and imperfect alignment could inaccurately result in the appearance of new hypoperfusion. To prevent this, we manually checked multiple structural landmarks for each sequence within every time point for every patient and found misalignment Ͻ3 voxels in any direction. In addition, isolated regions Ͻ1 mL were removed from the analysis to prevent inclusion of regions of misregistration or noise-induced variations.
Conclusions
We observed spatial heterogeneity of tissue perfusion in 15 tPA-treated patients with dynamic perfusion between tp1 and tp2. Reperfusion, nonreperfusion, normal perfusion, and new hypoperfusion were concurrently observed. Both nonreperfused and new hypoperfused tissue adversely influenced tissue infarction risk. Our results suggest that delay to tPA treatment and a large initial perfusion lesion may increase the risk of developing new hypoperfusion, leading to a worsened overall perfusion status after tPA treatment.
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